Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

491
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
491
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Ligand Binding Sites02:40

Ligand Binding Sites

12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Conserved Binding Sites01:49

Conserved Binding Sites

4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Protein Organization01:24

Protein Organization

6.2K
Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transformer-Based Deep Learning Model for Predicting Hemoglobin Response to Mircera® in Hemodialysis Patients.

Blood purification·2026
Same author

SARS-CoV-2 Spike Protein's Structural Dynamics Affect the Activity of the Bebtelovimab Antibody.

Journal of chemical information and modeling·2026
Same author

Pd-Catalyzed Hydroalkoxycarbonylation and Hydroxycarbonylation: DFT Mapping of Catalyst-Substrate Landscape for Product Selectivity.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Cutaneous Microvascular Functional Reserve is Associated with Kidney Function and Histopathologic Injury in CKD: The MAP-CKD Study.

medRxiv : the preprint server for health sciences·2026
Same author

Physical Activity Fragmentation and All-Cause Mortality in Hemodialysis Patients: Insights From Fitbit Study.

Kidney medicine·2026
Same author

Magnitude and Predictors of Antimicrobial Use-Related Drug Problems in Geriatric Inpatients: Evaluation of Pharmacist Interventions.

Current drug safety·2026

Related Experiment Video

Updated: May 29, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K

Linking machine learning and biophysical structural features in drug discovery.

Armin Ahmadi1, Shivangi Gupta2, Vineetha Menon2

  • 1Department of Biological Sciences, The University of Alabama in Huntsville, Huntsville, AL, United States.

Frontiers in Molecular Biosciences
|February 7, 2025
PubMed
Summary

Machine learning identified key pharmacophore features linked to protein conformations selected by ligands. This approach enhances drug discovery by providing a mechanism-driven understanding of binding interactions and improving candidate optimization.

Keywords:
chemical biologyconformational selectiondockingdrug discoveryensemble dockingmachine learningpharmacophore

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Related Experiment Videos

Last Updated: May 29, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Drug discovery

Background:

  • Understanding protein-ligand interactions is crucial for drug discovery.
  • Protein binding sites exhibit dynamic conformational changes.
  • Identifying key features driving these changes is challenging.

Purpose of the Study:

  • To identify pharmacophore features associated with ligand-specific protein conformations using machine learning.
  • To develop a mechanism-driven understanding of binding interactions.
  • To create a predictive framework for optimizing drug candidates.

Main Methods:

  • Applied machine learning (ML) to analyze pharmacophore features from protein-binding sites.
  • Utilized molecular dynamics simulations to generate ensembles of protein conformations.
  • Leveraged pharmacophore descriptors focusing on charge, hydrogen bonding, hydrophobicity, and aromaticity.

Main Results:

  • The ML framework prioritized features uniquely associated with ligand-selected conformations.
  • Achieved significant enrichment of true positive ligands, improving database enrichment by up to 54-fold.
  • Demonstrated the robustness of the approach across diverse protein targets.

Conclusions:

  • This study emphasizes the role of specific protein conformations in ligand binding.
  • The approach offers an interpretable and actionable method for drug discovery.
  • Combining ML and pharmacophoric analysis provides intuitive tools for lead optimization and rational drug design.